INMB vs. CYN

Last updated Aug 1, 2026

INMB (INmune Bio, Inc.) and CYN (CYNGN Inc.) are both stocks. INMB operates in Biotechnology (Healthcare), while CYN operates in Software - Application (Technology). Over the past 3 years, INMB returned -41.02%/yr vs -95.60%/yr for CYN. Their 0.18 correlation means their historical movements had little consistent relationship.

Performance

INMB vs. CYN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in INmune Bio, Inc. (INMB) and CYNGN Inc. (CYN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, INMB achieves a 12.18% return, which is significantly higher than CYN's -55.46% return.

INMB

• 1D: -1.13%
• 1M: 2.94%
• 6M: 10.06%
• YTD: 12.18%
• 1Y: -31.64%
• 3Y*: -41.02%
• 5Y*: -35.12%
• 10Y*: —
• ALL TIME*: -18.96%

CYN

• 1D: -2.75%
• 1M: -20.30%
• 6M: -39.77%
• YTD: -55.46%
• 1Y: -84.18%
• 3Y*: -95.60%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -91.07%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CYN CYNGN Inc.	$135.71K	$185.68K	$324.12K
INMB INmune Bio, Inc.	$483.35K	$1.25M	$1.23M

INMB vs. CYN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
INMB INmune Bio, Inc.	12.18%	-66.60%	-58.53%	77.60%	-37.84%	-44.11%
CYN CYNGN Inc.	-55.46%	-98.13%	-94.13%	-76.37%	-85.03%	-43.82%

Correlation

The correlation between INMB and CYN is 0.28, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.28
Correlation (3Y) Balances recent behavior with more history.	0.24
Correlation (All Time) Calculated using the full available price history since Oct 20, 2021	0.18

The correlation between INMB and CYN shifts across timeframes, from 0.18 (all time) to 0.28 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap INMB : $46.52M CYN : $7.51M
EPS INMB : -$1.56 CYN : -$3.46
PB Ratio INMB : 2.37 CYN : 0.23
Total Revenue (TTM) INMB : $0.00 CYN : $276.40K
Gross Profit (TTM) INMB : -$108.00K CYN : $95.11K
EBITDA (TTM) INMB : -$26.72M CYN : -$25.99M

Return for Risk

INMB vs. CYN — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

INMB

INMB Risk / Return Rank: 24
INMB Sharpe Ratio Rank: 22
INMB Sortino Ratio Rank: 24
INMB Omega Ratio Rank: 26
INMB Calmar Ratio Rank: 22
INMB Martin Ratio Rank: 27

CYN

CYN Risk / Return Rank: 4
CYN Sharpe Ratio Rank: 5
CYN Sortino Ratio Rank: 2
CYN Omega Ratio Rank: 3
CYN Calmar Ratio Rank: 1
CYN Martin Ratio Rank: 10

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

INMB vs. CYN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for INmune Bio, Inc. (INMB) and CYNGN Inc. (CYN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	INMB	CYN	Difference
Sharpe ratio: Return per unit of total volatility	-0.49	-0.95	+0.46
Sortino ratio: Return per unit of downside risk	-0.36	-2.30	+1.94
Omega ratio: Gain probability vs. loss probability	0.96	0.76	+0.21
Calmar ratio: Return relative to maximum drawdown	-0.59	-1.00	+0.41
Martin ratio: Return relative to average drawdown	-0.83	-1.34	+0.51

INMB vs. CYN - Sharpe Ratio Comparison

The current INMB Sharpe Ratio is -0.49, which is higher than the CYN Sharpe Ratio of -0.95. The chart below compares the historical Sharpe Ratios of INMB and CYN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

INMB vs. CYN - Drawdown Comparison

The maximum INMB drawdown since its inception was -95.98%, roughly equal to the maximum CYN drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for INMB and CYN.

Drawdown Indicators

	INMB	CYN	Difference
Max Drawdown Largest peak-to-trough decline	-95.98%	-100.00%	+4.02%
Max Drawdown (1Y) Largest decline over 1 year	-60.77%	-85.69%	+24.92%
Max Drawdown (3Y) Largest decline over 3 years	-92.01%	-99.99%	+7.98%
Max Drawdown (5Y) Largest decline over 5 years	-95.98%	—	—
Current Drawdown Current decline from peak	-93.72%	-100.00%	+6.28%
Average Drawdown Average peak-to-trough decline	-61.24%	-90.86%	+29.62%
Ulcer Index Depth and duration of drawdowns from previous peaks	43.21%	64.00%	-20.79%

Volatility

INMB vs. CYN - Volatility Comparison

INmune Bio, Inc. (INMB) has a higher volatility of 22.70% compared to CYNGN Inc. (CYN) at 16.56%. This indicates that INMB's price experiences larger fluctuations and is considered to be riskier than CYN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INMB	CYN	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.70%	16.56%	+6.14%
Volatility (6M) Calculated over the trailing 6-month period	53.53%	62.66%	-9.13%
Volatility (1Y) Calculated over the trailing 1-year period	73.53%	90.02%	-16.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	84.55%	195.34%	-110.79%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	92.63%	195.34%	-102.71%

Dividends

INMB vs. CYN - Dividend Comparison

Neither INMB nor CYN has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both INMB and CYN in my portfolio?

INMB and CYN have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, INMB or CYN?

INMB has higher volatility (22.70%) compared to CYN (16.56%). In terms of maximum drawdown, INMB dropped -95.98% vs CYN's -100.00%.

Which has better risk-adjusted returns?

INMB currently has the higher Sharpe Ratio (-0.49 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.